67 related articles for article (PubMed ID: 19160671)
1. Studying the subcellular localization and DNA-binding activity of FoxO transcription factors, downstream effectors of PI3K/Akt.
Essafi A; Gomes AR; Pomeranz KM; Zwolinska AK; Varshochi R; McGovern UB; Lam EW
Methods Mol Biol; 2009; 462():201-11. PubMed ID: 19160671
[TBL] [Abstract][Full Text] [Related]
2. Modulation of FoxO signaling in human hepatoma cells by exposure to copper or zinc ions.
Walter PL; Kampkötter A; Eckers A; Barthel A; Schmoll D; Sies H; Klotz LO
Arch Biochem Biophys; 2006 Oct; 454(2):107-13. PubMed ID: 16973122
[TBL] [Abstract][Full Text] [Related]
3. Is nuclear deficiency of FoxO1 due to increased growth factor/PI3K/Akt-signalling in acne vulgaris reversed by isotretinoin treatment?
Melnik BC
Br J Dermatol; 2010 Jun; 162(6):1398-400. PubMed ID: 20394627
[No Abstract] [Full Text] [Related]
4. PI3K/Akt/FoxO: a novel participant in signal transduction in bone cells under mechanical stimulation.
Ma Y; Wang H
Cell Biol Int; 2012 Oct; 36(10):923-6. PubMed ID: 22716317
[TBL] [Abstract][Full Text] [Related]
5. Chemical genetic analysis of FOXO nuclear-cytoplasmic shuttling by using image-based cell screening.
Zanella F; Rosado A; García B; Carnero A; Link W
Chembiochem; 2008 Sep; 9(14):2229-37. PubMed ID: 18756565
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte signaling: regulation of FoxO transcription factors by microRNAs.
Haftmann C; Stittrich AB; Sgouroudis E; Matz M; Chang HD; Radbruch A; Mashreghi MF
Ann N Y Acad Sci; 2012 Jan; 1247():46-55. PubMed ID: 22236474
[TBL] [Abstract][Full Text] [Related]
7. Regulation of influenza A virus induced CXCL-10 gene expression requires PI3K/Akt pathway and IRF3 transcription factor.
Lu X; Masic A; Liu Q; Zhou Y
Mol Immunol; 2011 Jul; 48(12-13):1417-23. PubMed ID: 21497908
[TBL] [Abstract][Full Text] [Related]
8. PIKE/nuclear PI 3-kinase signaling in preventing programmed cell death.
Ye K
J Cell Biochem; 2005 Oct; 96(3):463-72. PubMed ID: 16088938
[TBL] [Abstract][Full Text] [Related]
9. Autotaxin stimulates urokinase-type plasminogen activator expression through phosphoinositide 3-kinase-Akt-nuclear [corrected] factor kappa B signaling cascade in human melanoma cells.
Lee J; Duk Jung I; Gyo Park C; Han JW; Young Lee H
Melanoma Res; 2006 Oct; 16(5):445-52. PubMed ID: 17013094
[TBL] [Abstract][Full Text] [Related]
10. Nickel and copper ion-induced stress signaling in human hepatoma cells: analysis of phosphoinositide 3'-kinase/Akt signaling.
Eckers A; Reimann K; Klotz LO
Biometals; 2009 Apr; 22(2):307-16. PubMed ID: 18925359
[TBL] [Abstract][Full Text] [Related]
11. CD166 plays a pro-carcinogenic role in liver cancer cells via inhibition of FOXO proteins through AKT.
Yu W; Wang J; Ma L; Tang X; Qiao Y; Pan Q; Yu Y; Sun F
Oncol Rep; 2014 Aug; 32(2):677-83. PubMed ID: 24891117
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin.
Liu ZP; Wang Z; Yanagisawa H; Olson EN
Dev Cell; 2005 Aug; 9(2):261-70. PubMed ID: 16054032
[TBL] [Abstract][Full Text] [Related]
13. The PI3K-Akt pathway regulates calpain 6 expression, proliferation, and apoptosis.
Liu Y; Mei C; Sun L; Li X; Liu M; Wang L; Li Z; Yin P; Zhao C; Shi Y; Qiu S; Fan J; Zha X
Cell Signal; 2011 May; 23(5):827-36. PubMed ID: 21255642
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1.
Liu ZJ; Xiao M; Balint K; Soma A; Pinnix CC; Capobianco AJ; Velazquez OC; Herlyn M
FASEB J; 2006 May; 20(7):1009-11. PubMed ID: 16571776
[TBL] [Abstract][Full Text] [Related]
15. NF-kappaB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis.
Kang MJ; Ryu BK; Lee MG; Han J; Lee JH; Ha TK; Byun DS; Chae KS; Lee BH; Chun HS; Lee KY; Kim HJ; Chi SG
Gastroenterology; 2008 Dec; 135(6):2030-42, 2042.e1-3. PubMed ID: 18824170
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of disease: PI3K/AKT signaling in gastrointestinal cancers.
Michl P; Downward J
Z Gastroenterol; 2005 Oct; 43(10):1133-9. PubMed ID: 16220453
[TBL] [Abstract][Full Text] [Related]
17. Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
Dworakowska D; Wlodek E; Leontiou CA; Igreja S; Cakir M; Teng M; Prodromou N; Góth MI; Grozinsky-Glasberg S; Gueorguiev M; Kola B; Korbonits M; Grossman AB
Endocr Relat Cancer; 2009 Dec; 16(4):1329-38. PubMed ID: 19620247
[TBL] [Abstract][Full Text] [Related]
18. CNK1 is a novel Akt interaction partner that promotes cell proliferation through the Akt-FoxO signalling axis.
Fritz RD; Varga Z; Radziwill G
Oncogene; 2010 Jun; 29(24):3575-82. PubMed ID: 20383191
[TBL] [Abstract][Full Text] [Related]
19. PI3K-AKT pathway negatively controls EGFR-dependent DNA-binding activity of Stat3 in glioblastoma multiforme cells.
Ghosh MK; Sharma P; Harbor PC; Rahaman SO; Haque SJ
Oncogene; 2005 Nov; 24(49):7290-300. PubMed ID: 16007122
[TBL] [Abstract][Full Text] [Related]
20. A novel phosphatidylinositol 3-kinase (PI3K) inhibitor directs a potent FOXO-dependent, p53-independent cell cycle arrest phenotype characterized by the differential induction of a subset of FOXO-regulated genes.
Hill R; Kalathur RK; Callejas S; Colaço L; Brandão R; Serelde B; Cebriá A; Blanco-Aparicio C; Pastor J; Futschik M; Dopazo A; Link W
Breast Cancer Res; 2014 Dec; 16(6):482. PubMed ID: 25488803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
